249920-35-2

Upstream product

• 249920-33-0 ethyl 2,3,4-tri-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1->4)-2,3-di-O-benzyl-β-L-rhamnopyranosyl-(1->4)-2,3-di-O-benzoyl-6-O-benzyl-1-thio-β-D-glucopyranoside 
• 249920-32-9 ethyl 2,3-di-O-benzyl-β-L-rhamnopyranosyl-(1->4)-2,3-di-O-benzoyl-6-O-benzyl-1-thio-β-D-glucopyranoside 
• 192706-11-9 2-(trimethylsilyl)ethyl 6-O-benzyl-β-D-galactopyranoside 
• 169393-72-0 2,3,4-tri-O-acetyl-6-O-benzyl-α,β-D-galactopyranosyl trichloroacetimidate 
• 130515-87-6 2-(trimethylsilyl)ethyl 2,3,4-tri-O-acetyl-6-O-benzyl-β-D-galactopyranoside 
• 2916-68-9 2-(Trimethylsilyl)ethanol 
• 249920-34-1 2-(trimethylsilyl)ethyl 2,3,4-tri-O-acetyl-6-O-benzyl-β-D-galactopyranosyl-(1->4)-2,3-di-O-benzyl-β-L-rhamnopyranosyl-(1->4)-2,3-di-O-benzoyl-6-O-benzyl-β-D-glucopyranoside 

Relevant academic research and scientific papers

Synthesis of a disialylated hexasaccharide of Type VIII Group B Streptococcus capsular polysaccharide

As part of our program to design, develop and prepare protective vaccines against the bacterial pathogens Group B Streptococcus, we report the synthesis of a disialylated hexasaccharide. This hexasaccharide represents a portion of the serotype-specific ca